Tudor Investment Corp’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22,589
Closed -$611K 3216
2024
Q2
$611K Sell
22,589
-118,586
-84% -$2.47M ﹤0.01% 1715
2024
Q1
$2.59M Buy
141,175
+22,001
+18% +$349K 0.02% 900
2023
Q4
$1.46M Buy
119,174
+53,776
+82% +$504K 0.01% 1265
2023
Q3
$980K Buy
65,398
+51,904
+385% +$1.08M 0.01% 1309
2023
Q2
$438K Sell
13,494
-46,144
-77% -$1.69M 0.01% 1788
2023
Q1
$2.33M Buy
59,638
+16,961
+40% +$830K 0.04% 708
2022
Q4
$2.25M Buy
+42,677
New +$2.08M 0.04% 572
2022
Q2
Sell
-9,314
Closed -$385K 2600
2022
Q1
$385K Buy
+9,314
New +$328K 0.01% 1422
2021
Q2
Sell
-34,149
Closed -$1.73M 2019
2021
Q1
$1.73M Buy
+34,149
New +$1.9M 0.03% 585
2020
Q4
Sell
-4,056
Closed -$273K 1690
2020
Q3
$273K Buy
+4,056
New +$221K 0.01% 1021
2020
Q1
Sell
-10,046
Closed -$406K 1389
2019
Q4
$406K Buy
+10,046
New +$352K 0.02% 784

Other funds holding SILK

Tudor Investment Corp's SILK Position: Q3 2024 in Review

Tudor Investment Corp sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 22,589 shares — an estimated $611K sold.

Tudor Investment Corp first reported a position in SILK in Q4 2019 and held it in 11 quarters. The position peaked at $2.59M in Q1 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Tudor Investment Corp reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 22,589 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $611K.
  • Tudor Investment Corp first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • Tudor Investment Corp's Silk Road Medical, Inc. Common Stock position peaked at $2.59M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.